Welltower stock (US95040Q1040): Jefferies raises target to $248

Jefferies analyst Jonathan Petersen maintained a buy rating on Welltower (US95040Q1040) and raised the price target to $248 from $231, according to Futunn as of May 13, 2026. This adjustment reflects optimism about Welltower's capital allocation and operating performance in the seniors housing sector. The stock traded at $217.50 on NYSE as of May 13, 2026, per Marketscreener as of May 13, 2026.

As of: 13.05.2026

By the editorial team – specialized in equity coverage.

Welltower: core business model

Welltower Inc. operates as a self-administered real estate investment trust investing in healthcare infrastructure properties. Its portfolio includes over 2,500 seniors housing and wellness communities primarily in the United States, with additional exposure in the United Kingdom and Canada, according to Marketscreener as of May 13, 2026. The company focuses on rental housing for aging seniors at the intersection of housing and hospitality.

Main revenue and product drivers for Welltower

Welltower generates revenue primarily from seniors housing communities and wellness properties. Growth is fueled by disciplined capital allocation, a robust data science platform, and strong operating performance, as noted in recent coverage from Ad-hoc-News. These drivers position Welltower to benefit from demographic trends in aging populations across its core markets.

Industry trends and competitive position

The healthcare REIT sector benefits from rising demand for senior living amid an aging US population. Welltower's scale and focus on vibrant communities for mature renters give it a strong foothold, with outperformance versus benchmarks noted in performance comparisons as of recent data.

Why Welltower matters for US investors

Welltower's NYSE listing (WELL) and extensive US portfolio make it a key play for investors tracking healthcare real estate exposure tied to the US economy and demographic shifts. Its properties serve a growing segment of the US healthcare infrastructure market.

Conclusion

Welltower continues to show momentum through strategic capital moves and sector tailwinds, as evidenced by Jefferies' updated buy rating and target price increase. Investors monitor its performance amid healthcare REIT dynamics. The company's positioning in seniors housing underscores its relevance in a demographically driven market.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.